DVA — DaVita Inc.
$183.64-1.32%
Last close: · regular session
Last 60 sessions
Opening the full analysis uses 1 of your 3 free tickers today.
Chart, dilution, float and news for DVA in the TickerWise workspace.
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company provides disease management services to 16,000 patients in risk-based integrated care arrangements and 7,000 patients in other integrated care arrangements; vascular access services; clinical research programs; physician services; and comprehensive kidney care services. As of December 31, 2021, it provided dialysis and administrative services in the United States through a network of 2,815 outpatient dialysis centers serving approximately 203,100 patients; and operated 339 outpatient dialysis centers located in 10 countries outside of the United States serving approximately 39,900 patients. Further, the company provides acute inpatient dialysis services in approximately 850 hospitals and related laboratory services in the United States. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
Company profile
- Sector: Healthcare
- Industry: Medical - Care Facilities
- Country: US
- Exchange: NYSE
- Employees: 76,000
- Website: https://www.davita.com
Latest SEC filings for DVA
Latest DVA news
- DaVita HealthCare (DVA) Falls More Steeply Than Broader Market: What Investors Need to Know Read article
- DaVita Stock Gains 55.6% Year to Date: What's Behind the Rally? Read article
- DaVita, Fresenius drop as RFK Jr. is said to plan dialysis market reforms Read article
- DaVita HealthCare (DVA) Stock Moves -1.01%: What You Should Know Read article
- Why DaVita HealthCare (DVA) Outpaced the Stock Market Today Read article
- DaVita: After A 25% Drop, The Buyback Machine Is Cheap Again Read article
- Here's Why You Should Retain DaVita Stock in Your Portfolio for Now Read article
- DaVita Activates Emergency Response Efforts Ahead of Hurricane Isaias, Urges Kidney Patients to Prepare Early Read article
Opening the full analysis uses 1 of your 3 free tickers today.
Educational tool only — not investment advice.